Paper24847
Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata).
Claflin AJ and 8 others. Proc Natl Acad Sci U S A, 1978. Cited by 50 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata). Papers, record 24847. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24847
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Guanylate Cyclase | Major topic |
| Plant Extracts | Major topic |
| Prostatic Neoplasms | Major topic |
| Animals | |
| Cell Cycle | |
| Concanavalin A | |
| Cyclic GMP | |
| In Vitro Techniques | |
| Male | |
| Neoplasms, Experimental | |
| Thymidine |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11,888 | Activation of guanylate cyclase by streptozotocin and 1-methyl-1-nitrosourea. | Cancer Res | 1977 | https://conductscience.org/library/papers/11888 | PubMed |
| 2 | 12,374 | Guanylate cyclase activity in fetal, neonatal and adult rat heart. | J Mol Cell Cardiol | 1976 | https://conductscience.org/library/papers/12374 | PubMed |
| 3 | 13,797 | Hydrazine activation of guanylate cyclase: potential application to tobacco carcinogenesis. | Biochem Biophys Res Commun | 1977 | https://conductscience.org/library/papers/13797 | PubMed |
| 4 | 14,073,009 | PROSTATE CANCER IN THE RAT. | Natl Cancer Inst Monogr | 1963 | https://conductscience.org/library/papers/14073009 | PubMed |
| 5 | 14,859 | Decreased rat hepatic guanylate cyclase activity in streptozotocin-induced diabetes mellitus. | Diabetes | 1977 | https://conductscience.org/library/papers/14859 | PubMed |
| 7 | 173,021 | Cyclic guanosine monophosphate and cellular growth. | Science | 1975 | https://conductscience.org/library/papers/173021 | PubMed |
| 8 | 175,089 | The content and metabolism of cyclic adenosine 3', 5'-monophosphate and cyclic guanosine 3', 5'-monophosphate in adenocarcinoma of the human colon. | J Clin Invest | 1976 | https://conductscience.org/library/papers/175089 | PubMed |
| 9 | 176,557 | A simple ultrasensitive method for the assay of cyclic AMP and cyclic GMP in tissues. | Life Sci | 1976 | https://conductscience.org/library/papers/176557 | PubMed |
| 10 | 17,868 | Enhancement of human guanylate cyclase activity by chemical carcinogens. | Proc Soc Exp Biol Med | 1977 | https://conductscience.org/library/papers/17868 | PubMed |
| 11 | 20,099 | Isolation of a guanylate cyclase inhibitor from the balsam pear (Momordica charantia abreviata). | Biochem Biophys Res Commun | 1977 | https://conductscience.org/library/papers/20099 | PubMed |
| 12 | 239,404 | Increased particulate and decreased soluble guanylate cyclase activity in regenerating liver, fetal liver, and hepatoma. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/239404 | PubMed |
| 13 | 241,939 | Increases in cyclic GMP levels in brain and liver with sodium azide an activator of guanylate cyclase. | Nature | 1975 | https://conductscience.org/library/papers/241939 | PubMed |
| 14 | 4,153,265 | Activation of guanyl cyclase and intracellular cyclic GMP by fibroblast growth factor. | Nature | 1974 | https://conductscience.org/library/papers/4153265 | PubMed |
| 15 | 4,334,491 | Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. | J Biol Chem | 1972 | https://conductscience.org/library/papers/4334491 | PubMed |
| 16 | 4,342,973 | Guanosine 3':5'-cyclic monophosphate: a possible intracellular mediator of mitogenic influences in lymphocytes. | Proc Natl Acad Sci U S A | 1972 | https://conductscience.org/library/papers/4342973 | PubMed |
| 17 | 4,352,647 | Pleiotypic control by cyclic AMP: interaction with cyclic GMP and possible role of microtubules. | Proc Natl Acad Sci U S A | 1973 | https://conductscience.org/library/papers/4352647 | PubMed |
| 18 | 4,357,771 | Cyclic nucleotides as intracellular mediators of the expression of antigen-sensitive cells. | Nature | 1973 | https://conductscience.org/library/papers/4357771 | PubMed |
| 19 | 4,362,085 | Possible involvement of cyclic GMP in growth control of cultured mouse cells. | Nature | 1974 | https://conductscience.org/library/papers/4362085 | PubMed |
| 20 | 4,372,536 | Cyclic GMP stimulates lymphocyte nucleic acid synthesis. | Nature | 1974 | https://conductscience.org/library/papers/4372536 | PubMed |
| 21 | 4,645,593 | Immune responses in vitro. V. Role of mercaptoethanol in the mixed-leukocyte reaction. | Cell Immunol | 1972 | https://conductscience.org/library/papers/4645593 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32,726,914 | Bitter Melon (Momordica Charantia), a Nutraceutical Approach for Cancer Prevention and Therapy. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32726914 | PubMed |
| 29,182,587 | Recent Advances in Momordica charantia: Functional Components and Biological Activities. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/29182587 | PubMed |
| 27,452,666 | Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy. | Semin Cancer Biol | 2016 | https://conductscience.org/library/papers/27452666 | PubMed |
| 25,672,620 | Bitter melon juice targets molecular mechanisms underlying gemcitabine resistance in pancreatic cancer cells. | Int J Oncol | 2015 | https://conductscience.org/library/papers/25672620 | PubMed |
| 24,297,707 | Effect of α, β momorcharin on viability, caspase activity, cytochrome c release and on cytosolic calcium levels in different cancer cell lines. | Mol Cell Biochem | 2014 | https://conductscience.org/library/papers/24297707 | PubMed |
| 22,654,956 | Antileukemic Potential of Momordica charantia Seed Extracts on Human Myeloid Leukemic HL60 Cells. | Evid Based Complement Alternat Med | 2012 | https://conductscience.org/library/papers/22654956 | PubMed |
| 6,114,928 | Purified Clostridium difficile cytotoxin stimulates guanylate cyclase activity and inhibits adenylate cyclase activity. | Infect Immun | 1981 | https://conductscience.org/library/papers/6114928 | PubMed |
| 2,503,472 | Epidemiologic survey on lung cancer with respect to cigarette smoking and plant diet. | Jpn J Cancer Res | 1989 | https://conductscience.org/library/papers/2503472 | PubMed |
| 40,226 | Testosterone and its precursors and metabolites enhance guanylate cyclase activity. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/40226 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24847
GET https://conductscience.org/api/papers/v1/24847/references?page=2